Influence of blood pressure control and application of renin‐angiotensin‐aldosterone system inhibitors on the outcomes in COVID‐19 patients with hypertension
R Chen, J Yang, X Gao, X Ding, Y Yang… - The Journal of …, 2020 - Wiley Online Library
Hypertension is proved to be associated with severity and mortality in coronavirus disease
2019 (COVID‐19). However, little is known about the effects of pre‐admission and/or in …
2019 (COVID‐19). However, little is known about the effects of pre‐admission and/or in …
Chronic use of renin–angiotensin–aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis
Á Aparisi, P Catalá, IJ Amat-Santos, M Marcos-Mangas… - Medicina Clínica, 2022 - Elsevier
Background Hypertension is a prevalent condition among SARS-CoV-2 infected patients.
Whether renin–angiotensin–aldosterone system (RAAS) inhibitors are beneficial or harmful …
Whether renin–angiotensin–aldosterone system (RAAS) inhibitors are beneficial or harmful …
Effects of renin–angiotensin–aldosterone inhibitors on early outcomes of hypertensive COVID-19 patients: a randomized triple-blind clinical trial
F Najmeddin, M Solhjoo, H Ashraf… - American journal of …, 2021 - academic.oup.com
Background The role of angiotensin-converting enzyme inhibitors (ACEis) and angiotensin
receptor blockers (ARBs) has been addressed in some studies related to the current …
receptor blockers (ARBs) has been addressed in some studies related to the current …
Clinical features of COVID-19 in patients with essential hypertension and the impacts of renin-angiotensin-aldosterone system inhibitors on the prognosis of COVID-19 …
W Pan, J Zhang, M Wang, J Ye, Y Xu, B Shen, H He… - …, 2020 - Am Heart Assoc
Hypertension is one of the most common comorbidities in patients with coronavirus disease
2019 (COVID-19). This study aimed to clarify the impact of hypertension on COVID-19 and …
2019 (COVID-19). This study aimed to clarify the impact of hypertension on COVID-19 and …
Blood pressure control and adverse outcomes of COVID-19 infection in patients with concomitant hypertension in Wuhan, China
Hypertension is a common comorbidity in hospitalized patients with COVID-19 infection.
This study aimed to estimate the risks of adverse events associated with in-hospital blood …
This study aimed to estimate the risks of adverse events associated with in-hospital blood …
Impact of renin–angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: a retrospective observational study
Y Zhong, L Zhao, G Wu, C Hu, C Wu… - Journal of …, 2020 - journals.sagepub.com
Objective Association of angiotensin-converting enzyme inhibitors (ACEI) or angiotensin
receptor blockers (ARB) use with coronavirus disease 2019 (COVID-19) remains …
receptor blockers (ARB) use with coronavirus disease 2019 (COVID-19) remains …
The use of renin–angiotensin–aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID‐19 patients: a systematic review …
Y Wang, B Chen, Y Li, L Zhang, Y Wang… - Journal of medical …, 2021 - Wiley Online Library
Renin–angiotensin–aldosterone system (RAAS) inhibitors, including angiotensin‐converting
enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are one of the most …
enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are one of the most …
Impact of arterial hypertension and use of antihypertensive pharmacotherapy on mortality in patients hospitalized due to COVID-19: the CRACoV-HHS study
W Wojciechowska, M Terlecki, M Klocek, A Pac… - …, 2022 - Am Heart Assoc
Background: Cardiovascular diseases including arterial hypertension are common
comorbidities among patients hospitalized due to COVID-19. We assessed the influence of …
comorbidities among patients hospitalized due to COVID-19. We assessed the influence of …
Renin–angiotensin–aldosterone system inhibitors and the risk of mortality in patients with hypertension hospitalised for COVID-19: systematic review and meta …
Objective The association between the use of renin–angiotensin–aldosterone (RAAS)
inhibitors and the risk of mortality from COVID-19 is unclear. We aimed to estimate the …
inhibitors and the risk of mortality from COVID-19 is unclear. We aimed to estimate the …
Impact of treatment with renin–angiotensin system inhibitors on clinical outcomes in hypertensive patients hospitalized with COVID-19
M Negreira-Caamaño, J Piqueras-Flores… - High Blood Pressure & …, 2020 - Springer
Introduction Concerns have been raised about the possible harmfulness of angiotensin-
converter enzyme inhibitors (ACEi) and aldosterone receptor blockers (ARB) in patients with …
converter enzyme inhibitors (ACEi) and aldosterone receptor blockers (ARB) in patients with …
相关搜索
- covid 19 mortality in patients
- outcomes in covid angiotensin aldosterone
- outcomes in covid patients with hypertension
- patients with hypertension angiotensin aldosterone
- covid 19 renin angiotensin
- effects of renin aldosterone inhibitors
- early outcomes aldosterone inhibitors
- essential hypertension renin angiotensin
- covid 19 clinical outcomes
- covid 19 arterial hypertension
- hypertensive covid use of renin
- patients with hypertension risk of mortality
- hypertensive patients treatment with renin
- clinical outcomes treatment with renin
- chronic use aldosterone inhibitors
- effects of renin early outcomes